Traxis Partners’s Idexx Laboratories IDXX Stock Holding History

Traxis Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-30,000	Closed	-$1.34M	–	20
2013 Q2	$1.34M	Buy	+30,000	New	+$1.31M	1.04%	48

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Traxis Partners's IDXX Position: Q3 2013 in Review

Traxis Partners sold out of Idexx Laboratories (IDXX) in Q3 2013, closing a stake of 30,000 shares — an estimated $1.34M sold.

Traxis Partners first reported a position in IDXX in Q2 2013 and held it in 1 quarter. The position peaked at $1.34M in Q2 2013. 274 funds tracked by Wall St. Rank hold IDXX as of Q3 2013.

Traxis Partners reported no remaining Idexx Laboratories position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 30,000 Idexx Laboratories shares in Q3 2013, an estimated $1.34M.
Traxis Partners first reported a position in Idexx Laboratories in Q2 2013 and held it in 1 quarter.
Traxis Partners's Idexx Laboratories position peaked at $1.34M in Q2 2013.
274 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.